Test Comparison - Breast Recurrence Score®

Learn how the Breast Recurrence Score compares to traditional assessment methods, genetic tests, and other genomic assays.

Benefits and Applications of Oncotype DX Breast Recurrence Score

Natalie Wilgus on LinkedIn: About Us

MedCity News on LinkedIn: The FDA approved AstraZeneca's Truqap as a new treatment for advanced…

Comparative survival analysis of multiparametric tests—when

PDF) Histopathologic variables predict Oncotype DX™ Recurrence

Bret Nelson on LinkedIn: Explore the Report │ OncoExTra™

Neil Yman on LinkedIn: Approximately 15 years ago I met Pr. Giuseppe Viale and I have had several…

Node Positive Evidence - Breast Recurrence Score® Test│ Precision

2023 San Antonio Breast Cancer Symposium

Mammaprint® Comparison - Breast Recurrence Score®│ Precision Oncology

New Online App May Help Doctors Predict Risk of Breast Cancer

Prediction of late distant recurrence in patients with oestrogen